Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications
Cardiovascular Trials in Hemodialysis: Closing the Evidence Gap.
Journal: Journal of the American College of Cardiology
Published: March 10, 2025
Effects of Clazakizumab on Anemia and Iron Metabolism in Patients with Kidney Failure.
Journal: Journal of the American Society of Nephrology : JASN
Published: February 05, 2025
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction.
Journal: The New England journal of medicine
Published: April 08, 2024
Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI.
Journal: Journal of the American College of Cardiology
Published: March 12, 2024
ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future.
Journal: Current atherosclerosis reports
Published: March 25, 2022
Post-Discharge Bleeding and Mortality Following Acute Coronary Syndromes With or Without PCI.
Journal: Journal of the American College of Cardiology
Published: February 21, 2020
Pharmacometric analyses to characterize the effect of CSL112 on apolipoprotein A-I and cholesterol efflux capacity in acute myocardial infarction patients.
Journal: British journal of clinical pharmacology
Published: January 03, 2020
Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction.
Journal: American heart journal
Published: November 21, 2019
Effect of Alirocumab on Mortality After Acute Coronary Syndromes.
Journal: Circulation
Published: May 24, 2019
Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial.
Journal: European heart journal
Published: February 08, 2019
Last Updated: 09/26/2026